Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Wegovy Reduces BMI in Kids With Obesity as Young as 6

(MedPage Today) -- NATIONAL HARBOR, Md. -- Young children ages 6 to 11 years with obesity lost significant weight with the GLP-1 medication semaglutide (Wegovy), according to results from the phase III STEP Young trial. At week 68, mean body...

Wegovy Reduces BMI in Kids With Obesity as Young as 6

We haven't written up this one. MedPage Today has the full story — the link below goes straight to it.

This story

This is one outlet's version. Read the fullest account.

Every outlet that reported this, and when →

Read the original at medpagetoday.com →

More in Health & Medicine

More from Monday 16 November →